Thereās a growing conversation happening right now around breast cancer screening.
And itās one that deserves more nuance than:
š āJust get your annual mammogram.ā
Because the truth isā¦
Mammography is not a perfect tool.
ā ļø The Downfalls of Routine Mammography
1. Cumulative Radiation Exposure
Mammograms use ionizing radiation.
Is one scan dangerous? Mildly.
But repeated exposure, year after year, decade after decadeā¦
š That becomes a cumulative burden on the body.
Especially for women already at higher genetic risk. (Like me!)
2. High False Positive Rates
Up to 50ā60% of women will experience a false positive over time.
That means:⢠Unnecessary imaging⢠Biopsies⢠Anxiety and stress
Weāve normalized a system that often creates fear⦠without clear answers.
3. Overdiagnosis
Not every detected tumor is life-threatening.
Some are slow-growing and may never cause harmā¦
Yet are still treated aggressively.
š Detection without context can lead to overtreatment.
4. Not Effective for Dense Breast Tissue
Many women (especially lean, athletic, or younger women) have dense breast tissue.
Mammograms often:
ā Miss tumors in dense tissue
ā Provide a false sense of security
5. A System Focused on Detection ā Not Cause
This is the biggest issue.
Mammograms look for
:š Whatās already there
They do NOT address:
⢠Why the tissue became vulnerable
⢠Whatās driving abnormal cell growth
⢠The internal terrain that allowed it
šæ Our Approach Is Different
At Bedrock, we donāt rely on a single tool.
We take a terrain + strategy approach.
1ļøā£ We Assess Risk First
Not every woman should follow the same screening schedule.
Factors matter
:⢠Genetics (BRCA, family history)
⢠Metabolic health
⢠Hormonal patterns
⢠Lifestyle + toxin exposure
š āAssess, donāt guess.ā
2ļøā£ We Use Thermography as a Functional Tool
Thermography looks at:
⢠Heat patterns
⢠Blood flow
⢠Inflammatory changes
ā No radiation
ā Non-invasive
ā Can detect early physiological changes
This gives us insight into function before structure.
3ļøā£ We Follow with Ultrasound (When Needed)
Ultrasound helps:
:⢠Visualize dense tissue
⢠Differentiate cysts vs solid masses
⢠Provide structural clarity
ā No radiation
ā Excellent complement to thermography
4ļøā£ We Support the Terrain (This Is the Missing Piece)
This is where everything changes.
We focus on:
⢠Insulin resistance
⢠Chronic inflammation
⢠Estrogen metabolism
⢠Detox pathways
⢠Mitochondrial health
Because cancer doesnāt just āappear.ā
š It develops in a compromised environment.
āļø Letās Be Clear
This is NOT about fear.
And itās not about ignoring screening.
Itās about moving away from:
ā One-size-fits-all, annual imaging without context
And toward:
ā Personalized strategy
ā Smarter use of technology
ā Addressing root cause, not just detection
š¬ Final Thought
Early detection matters.
But so does why the body allowed the problem in the first place.
If we only focus on finding diseaseā¦
We miss the opportunity to prevent the environment that creates it.
š Next Steps
If you want to approach your health differently:
⢠Start with the Bedrock Assessment
⢠Learn your personal risk factors
⢠Build a strategy that actually makes sense for your body
ā
Inside Bedrock Nation, this is exactly what we do:
Fuel ā Repair ā Restore
STUDIES & DOCUMENTATION:
š 1. False Positives in Mammography ā What the Research Shows
š¬ Key Studies & Findings
š High lifetime probability of false positives
* A large review found:
* ~50% of women will experience at least one false-positive over 10 years of annual screening
* U.S. data:
* ~30% 10-year false-positive rate (varies by frequency + population)
āø»
š Per-screen false positives
* National Cancer Institute data:
* About 10% false-positive rate per screening round
āø»
š Cumulative risk over repeated screening
* European cohort data:
* ~20% risk after 10 screening rounds
* Another cohort:
* 18ā38% cumulative false-positive risk depending on factors like symptoms
āø»
š Annual screening increases false positives
* Comparative data:
* 61% (annual) vs 42% (biennial) false-positive rates over time
āø»
š Long-term implications
* 2023 cohort study (~500,000 women):
* False positives associated with:
* Higher long-term breast cancer incidence
* Increased mortality risk over 20 years
āø»
š Clinical consequences
* Major reviews (e.g., U.S. Preventive Services Task Force):
* False positives lead to:
* Additional imaging
* Biopsies
* Psychological distress
āø»
š§ Bottom Line (Evidence-Based)
* False positives are:
* Common
* Cumulative
* More likely with frequent screening
* They carry:
* Psychological burden
* Procedural risk
* Long-term surveillance implications
āø»
ā¢ļø 2. Cumulative Radiation Exposure ā What Studies Say
š¬ Key Evidence & Reviews
š Radiation is a recognized harm of screening
* Major guideline review:
* Mammography harms include:
* Radiation exposure
* False positives
* Overdiagnosis
āø»
š Lifetime cumulative exposure matters
* Evidence reviews highlight:
* Radiation risk is low per scan
* But accumulates over repeated imaging
āø»
š Biological plausibility (important point)
* Ionizing radiation:
* Causes DNA damage
* Can contribute to carcinogenesis over time
This is well-established in radiation biology (not debated in mainstream literature)
āø»
š Risk-benefit framing in literature
* Reviews emphasize:
* Radiation risk is small individually
* But must be considered in:
* Younger women
* High-frequency screening
* Genetically susceptible populations
āø»
š Quantitative context
* Screening literature consistently frames radiation as:
* A recognized but relatively low risk per exposure
* Relevant over decades of repeated imaging
āø»
āļø 3. Overdiagnosis (Important Add-On)
Since this always comes up alongside false positives:
* Estimated:
* ~12.6% overdiagnosis rate in one 2023 analysis
* Broader estimates:
* Range widely (0ā54% depending on methodology)
š This variability is exactly why the topic remains debated.
āø»
𧬠What the research actually shows:
⢠Up to 50% of women experience a false-positive mammogram over time
⢠False positives often lead to additional imaging, biopsies, and long-term anxiety
⢠The risk increases with more frequent screening
⢠Mammography uses ionizing radiation, which is low per scanābut cumulative over decades
⢠Overdiagnosis is real, with estimates ranging widely depending on the study
āø»
Translation:
š Mammography is not a ārisk-free screening toolā
š Itās a tool with trade-offs
āø»
š„ Strategic Insight
Most people stop at:
āScreen or donāt screenā
But the literature actually supports a more sophisticated view:
ā Risk-based screening
ā Frequency matters
ā Modality matters
ā Individual biology matters
Sources: